Evidence map›Paper›PMID 37916289›Full record

ArticleAmerican journal of physiology. Renal physiology2024

β

Ehtesham Arif, Danira Medunjanin, Ashish Solanki, Xiaofeng Zuo, Yanhui Su, Yujing Dang, Brennan Winkler, Kasey Lerner, Ahmed I Kamal, Oleg Palygin and 4 more

Open access · greenAbstract read
In one paragraph

Article in American journal of physiology. Renal physiology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed, 1 pooled it
1.6field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 1 synthesis or guideline pooled it, 8 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Review
  5. βBiochemistry research international · 2025
    Review
4 · The record

Corrections and comments

  • Commented on by
    β2024
5 · Who and what money

Authors and funding

14 authors at 1 institution in 1 country.

Ehtesham ArifDepartment of Medicine, Medical University of South Carolina, Charleston, South Carolina, United States.ORCID 0000-0001-9638-3189
Danira MedunjaninDepartment of Public Health Sciences, Medical University of South Carolina, Charleston, South Carolina, United States.ORCID 0000-0001-7197-2518
Ashish SolankiDepartment of Medicine, Medical University of South Carolina, Charleston, South Carolina, United States.ORCID 0000-0002-5043-1699
Xiaofeng ZuoDepartment of Medicine, Medical University of South Carolina, Charleston, South Carolina, United States.
Yanhui SuDepartment of Medicine, Medical University of South Carolina, Charleston, South Carolina, United States.
Yujing DangDepartment of Medicine, Medical University of South Carolina, Charleston, South Carolina, United States.
Brennan WinklerDepartment of Medicine, Medical University of South Carolina, Charleston, South Carolina, United States.ORCID 0000-0002-8340-9017
Kasey LernerDepartment of Medicine, Medical University of South Carolina, Charleston, South Carolina, United States.
Ahmed I KamalDepartment of Medicine, Medical University of South Carolina, Charleston, South Carolina, United States.ORCID 0000-0003-1925-3158
Oleg PalyginDepartment of Medicine, Medical University of South Carolina, Charleston, South Carolina, United States.ORCID 0000-0002-3680-5527
Marc-Andre CornierDepartment of Medicine, Medical University of South Carolina, Charleston, South Carolina, United States.
Bethany J WolfDepartment of Public Health Sciences, Medical University of South Carolina, Charleston, South Carolina, United States.ORCID 0000-0002-7124-5158
Kelly J HuntDepartment of Public Health Sciences, Medical University of South Carolina, Charleston, South Carolina, United States.ORCID 0000-0001-8999-3587
Joshua H LipschutzDepartment of Medicine, Medical University of South Carolina, Charleston, South Carolina, United States.ORCID 0000-0002-7787-8503
Medical University of South Carolina · US

Funding

The exocyst in ciliogenesis and cystogenesisI01BX000820 · VA · RALPH H JOHNSON VA MEDICAL CENTER · PI JOSHUA H LIPSCHUTZ · 2011 to 2026
–
The role of beta agonists in the treatment of chronic kidney diseaseI01CX002391 · VA · RALPH H JOHNSON VA MEDICAL CENTER · PI JOSHUA H LIPSCHUTZ · 2023 to 2026
–
Improving Analysis of Endogenous Multimodal Treatments for Use in Geriatrics Health Outcomes StudiesI01HX002237 · VA · VA BOSTON HEALTH CARE SYSTEM · PI GARRIDO, MELISSA M · 2018 to 2021
–
Charleston Health Equity and Rural Outreach Innovation Center (HEROIC)I50HX001229 · VA · RALPH H JOHNSON VA MEDICAL CENTER · PI EGEDE, LEONARD E. · 2015 to 2015
–
BLRD VA I01 BX000820CSRD VA I01 CX002391Dialysis Clinics (DCI) no numberHSRD VA I50 HX001229HSRD VA SDR 02-237U.S. Department of Veterans Affairs (VA) BX000820U.S. Department of Veterans Affairs (VA) CX002391U.S. Department of Veterans Affairs (VA) HX001229
6 · The paper itself

Abstract

We have previously shown that the long-acting β

Indexed as

Diabetes Mellitus, Type 1Diabetes Mellitus, Type 2Diabetic NephropathiesKidney Failure, ChronicPulmonary Disease, Chronic ObstructiveAdrenergic beta-2 Receptor AgonistsAnimalsFormoterol FumarateHumansMiceReceptors, AdrenergicStreptozocinAdrenergic beta-2 Receptor AgonistsFormoterol FumarateReceptors, AdrenergicStreptozocindiabetesnephropathyβ-agonist

Identifiers

PMID37916289
PMCPMC11194047
OpenAlexW4388226656

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.